Body

Mobile phone technology could help to beat bad practices in healthcare delivery, research suggests.

Innovations such as apps offer opportunities for improving governance in the healthcare sector, particularly in low and middle income countries, the study found.

Experts say that good governance is essential for ensuring citizens have fair access to high quality healthcare.

Corruption, fraud, inefficiency and discrimination are major barriers to medical care provision in many developing countries.

Scientists have developed an endoscope that uses near-infrared light to spot early warning signs of oesophageal - food pipe - cancer, according to research published in the Journal of Biomedical Optics today.

Researchers at the Cancer Research UK Cambridge Institute sprayed a dye on oesophageal tissue samples taken from people with Barrett's oesophagus - a condition that increases the risk of developing oesophageal cancer. The dye sticks to healthy oesophageal cells but not to pre-cancerous cells.

Although chemotherapy can sometimes cure acute myeloid leukemia and other hematologic cancers, many patients experience relapses when their tumors become resistant to available chemotherapies. This resistance may be caused by the survival and proliferation of chemotherapy-resistant cells that were already present in the tumor prior to treatment. Studying the characteristics of these cells could help researchers understand and develop better approaches to target chemotherapy-resistant cancers.

Twins should be delivered at 37 weeks' gestation to minimise stillbirths and newborn deaths, and there is no clear evidence to support routine delivery before 36 week's gestation, finds a large international study in The BMJ today.

It is well known that the risk of stillbirth is higher in twin pregnancies than in singleton pregnancies. Uncomplicated twin pregnancies are often delivered early in an attempt to prevent stillbirth, but the optimal gestational age for delivery that minimises risks to newborns is not known.

A new metric, known as the Relative Citation Ratio (RCR), will allow researchers to measure the influence of a scientific article, regardless of publication and scientific field. While RCR cannot replace expert review, it does overcome many of the issues faced by previous metrics. RCR was developed by scientists with the Office of Portfolio Analysis (OPA), Division of Program Coordination, Planning and Strategic Initiatives (DPCPSI), part of the National Institutes of Health. A description of the new metric will be published in PLOS Biology on Sept. 6, 2016.

Scientists at Queen Mary University of London (QMUL) have analysed the twin pregnancies of more than 30,000 women to identify the ideal delivery period in an attempt to reduce rates of stillbirth.

In the largest review of its kind the researchers recommend that in the case of pregnancies without complications, women with dichorionic twins (twins with separate placenta) should be offered delivery after 37 weeks. They also recommend that women with monochorionic twins (twins that share the same placenta) should not be offered delivery before 36 weeks.

Research led by The Australian National University (ANU) has found doctors around the world are over diagnosing the most common thyroid cancer, creating an artificial epidemic that costs billions of dollars each year in unnecessary medical costs.

Lead researcher Associate Professor Suhail Doi said diagnoses of differentiated thyroid cancer globally had increased three-fold during the past 25 years despite no change to the disease's low death rate.

Johns Hopkins researchers report evidence from mouse studies that a "repurposed" drug that would be expected to improve the immune system response of tuberculosis patients may be increasing resistance to the antibiotic drugs these patients must also take.

The findings, which involve one of the new so-called host-directed therapies for TB, are a cautionary note on use of these adjunct approaches designed to fight active TB by increasing the efficiency of antimicrobials drug, rather than working directly against the TB bacillus, as antimicrobials do.

Edible ginger-derived nano-lipids created from a specific population of ginger nanoparticles show promise for effectively targeting and delivering chemotherapeutic drugs used to treat colon cancer, according to a study by researchers at the Institute for Biomedical Sciences at Georgia State University, the Atlanta Veterans Affairs Medical Center and Wenzhou Medical University and Southwest University in China.

Imagine trying to fly a kite without a tail. It swoops and loops and wiggles and finally crashes down into the ground. A kite without a tail is unstable, but add a tail at the right place, and your kite will fly steady.

WASHINGTON -- Scientists have built a new sensor that can detect the potentially deadly E.coli bacteria in 15-20 minutes, much faster than traditional lab tests. E.coli can be transmitted in contaminated food and water, posing particular risks to children and the elderly. In the late spring of 2011 a serious outbreak of E.coli bacteria sickened thousands of people in Germany and killed more than 50.

WASHINGTON, Sept. 6, 2016 -- Thanks to a new, cheap and accurate DNA-editing technique called CRISPR-Cas9, targeted genetic modification in humans is no longer just the realm of science fiction. Both the British and U.S. governments recently gave scientists the thumbs-up to edit DNA in human embryos and adults using CRISPR. So does this mean that we can trim out genetic diseases or mutations? Or maybe even add in abilities like infrared vision, possibly creating a designer-baby dystopia?

RESEARCH TRIANGLE PARK, NC--Steering new college students into remedial classes can boost a poorly prepared student's chances of success, but doesn't appear to benefit students with a stronger academic background, RTI International researchers have found.

(Bethesda, MD, Sept. 06, 2016) - A prominent physician scientist supported by the National Foundation of Cancer Research (NFCR), Dr. Daniel Haber, and his team at the Massachusetts General Hospital Cancer Center have identified a dynamic gene expression in metastatic breast cancer that may contribute to disease progression and resistance to treatment experienced by many patients. Tumors can evolve in response to treatment and they may acquire new genetic features that may make them resistant to drugs and cause disease progression.

A new study by investigators at Brigham and Women's Hospital (BWH) has found that a rise in prostate-specific antigen (PSA) levels in healthy men who have previously been treated for prostate cancer is significantly associated with a 1.6-fold increased risk of death. The team also studied men with prostate cancer who had another illness such as a history of heart attack or stroke, and did not find that PSA failure was predictive of the risk of death in these men.